24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Carcinoma Industry, March 2015 Market Reports from Top Publishers

You might be interested in: cancer, diagnostic, immunodiagnostic, neck cancer, therapeutics, medical equipment, bladder cancer, cervical cancer, biotherapeutics, breast cancer, esophageal cancer, hepatitis b.


 
1-10 of 73 reports for Carcinoma

Metastatic Renal Cell Carcinoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Metastatic Renal Cell Carcinoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Metastatic Renal Cell Carcinoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015 Summary Global Markets Direct's, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015', provides an overview of the Metastatic Renal ...

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Tikcro Technologies, Ltd. (Symbol:TIKRF) SWOT Analysis, Strategy, Revenues and Profits

Tikcro Technologies, Ltd. (Symbol:TIKRF) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Gastroesophageal (GE) Junction Carcinomas - Pipeline Review, H2 2014', provides an overview of the ...

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H2 2014', ...

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • December 2014
  • by Global Data

EpiCast Report: Cushing's Syndrome - Epidemiology Forecast to 2023 Summary Cushing's syndrome (CS) is a rare disorder caused by prolonged exposure to excess amounts of circulating free glucocorticoids, ...

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2014', provides an overview ...

Hepatocellular Carcinoma - Pipeline Review, H2 2014

Hepatocellular Carcinoma - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Hepatocellular Carcinoma - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Hepatocellular Carcinoma - Pipeline Review, H2 2014', provides an overview of the Hepatocellular Carcinoma's therapeutic ...

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2014', provides an ...

About 1 800 reports for Carcinoma

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2015
    56 pages
  • Cancer  

  • United States  

    North America  

View report >

11 Companies for Carcinoma

Read our Company Profiles

Novartis Inc.

Switzerland

Amgen Inc.

United States

Eli Lilly and Co.

United States

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.